<code id='5AC9531F06'></code><style id='5AC9531F06'></style>
      • <acronym id='5AC9531F06'></acronym>
      <center id='5AC9531F06'><center id='5AC9531F06'><tfoot id='5AC9531F06'></tfoot></center><abbr id='5AC9531F06'><dir id='5AC9531F06'><tfoot id='5AC9531F06'></tfoot><noframes id='5AC9531F06'>
      • <optgroup id='5AC9531F06'><strike id='5AC9531F06'><sup id='5AC9531F06'></sup></strike><code id='5AC9531F06'></code></optgroup>
        5. <b id='5AC9531F06'><label id='5AC9531F06'><select id='5AC9531F06'><dt id='5AC9531F06'><span id='5AC9531F06'></span></dt></select></label></b><u id='5AC9531F06'></u>
          <i id='5AC9531F06'><strike id='5AC9531F06'><tt id='5AC9531F06'><pre id='5AC9531F06'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-09-28 01:49:33 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：1439
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          David Sabatini, ex
                                
                            
          Next article：  
                                      
                                          Duchenne breakthrough therapy leaves behind pioneering families
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles